Skip to content
← Full study record

NCT03782064 · MORE INFO

Limitations, agreements, and source contact

Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma · Source last updated 2023-06-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
Due to withdrawal of funding, this study was halted prematurely. Only two participants were treated and we were unable to analyze the data in any meaningful way due to the small sample size.
point Of Contact
email
eklogan@bidmc.harvard.edu
organization
Beth Israel Deaconess Medical Center
phone
6176675984
title
Emma Logan, Director of Research Nursing
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
Due to withdrawal of funding, this study was halted prematurely. Only two participants were treated and we were unable to analyze the data in any meaningful way due to the small sample size.
point Of Contact
email
eklogan@bidmc.harvard.edu
organization
Beth Israel Deaconess Medical Center
phone
6176675984
title
Emma Logan, Director of Research Nursing

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice